Chinese General Hospital and Medical Center Expands Services with Theranostics for Advanced Prostate Cancer
The Chinese General Hospital and Medical Center (CGHMC) has recently taken significant strides in expanding access to state-of-the-art technology for patients with advanced prostate cancer. The Department of Nuclear Medicine and Theranostics, in coordination with a multispecialty team of physicians, performed its first administration of Lutetium-177 Prostate-Specific Membrane Antigen Radioligand Therapy (Lu-177 PRLT). The introduction […]